Related Experiment Videos
Novel trinucleotide deletion in Fabry's disease
M A Cariolou1, M Christodoulides, P Manoli
1Department of Molecular Genetics, Cyprus Institute of Neurology and Genetics, Nicosia.
Human Genetics
|April 1, 1996
Summary
Researchers identified a novel alpha-galactosidase A gene deletion in a Fabry disease patient. This genetic mutation is associated with severe symptoms and a new skin marker: diffuse facial telangiectasias.
Area of Science:
- Genetics
- Molecular Biology
- Dermatology
Background:
- Fabry disease is a rare genetic disorder caused by mutations in the alpha-galactosidase A gene.
- Clinical manifestations typically include severe systemic complications.
- Cutaneous findings are common but specific markers for disease severity are still being investigated.